Do you want to visit this external website and leave amgenpro.com.au?
You are now leaving this Amgen Australia website. Amgen Australia assumes no responsibility for, and exercises no control over, the organizations, opinions, or accuracy of the information on the server or website you are redirected to.
Do you want to visit this external website and leave amgenpro.com.au?
You are now leaving this Amgen Australia website. Amgen Australia assumes no responsibility for, and exercises no control over, the organizations, opinions, or accuracy of the information on the server or website you are redirected to.
You can paste this link into an email or message to share this resource with your patient.
Cardiovascular disease is a leading global health concern affecting nearly 240 million people worldwide.1 While there are many potential causes of cardiovascular disease, more than 80% of cardiovascular events are preventable.2
Building on more than four decades of experience in developing biotechnology medicines for patients with serious illnesses, Amgen is dedicated to advancing care for and improving the lives of patients with cardiovascular disease. Through research and development, as well as partnerships, Amgen is targeting some of the most significant and complex contributors to cardiovascular disease.
AmgenPro is intended for healthcare professionals in Australia
Login or create an AmgenPro account to access the latest updates on our products, medical resources and patient programs.